Investment Summary

Adams Street Partners Invests In Icosavax

On October 3, 2019, asset manager Adams Street Partners invested in life science company Icosavax

Investment Highlights
  • This is Adams Street Partners’ 20th transaction in the Life Science sector.
  • This is Adams Street Partners’ 118th transaction in the United States.
  • This is Adams Street Partners’ 3rd transaction in Washington.
Investment Fate
  • Icosavax went public in 2021.
  • Icosavax was sold to a strategic buyer in 2023 for 1.1B USD.

Investment Summary

Date 2019-10-03
Target Icosavax
Sector Life Science
Investor(s) Adams Street Partners
Deal Type Venture

Target

Icosavax

Seattle, Washington, United States
Icosavax is a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Icosavax was founded in 2017 and is based in Seattle, Washington.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Adams Street Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 1972
PE ASSETS 60.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Adams Street Partners is a diversified, global investment firm that targets direct, fund of funds, and secondary investments. Adams' direct investing group covers co-investments in buyout transactions, as well as growth equity and venture capital commitments. The direct buyout and growth equity team looks to commit $5 to $30 million per transaction. For venture related investments, commitments of $5 to $20 million are provided to companies in the technology, life sciences and technology enabled services sectors. Typically, target companies have received prior financing from early stage venture firms and are seeking additional capital to fund product development and commercialization. Adams Street Partners was formed in 1972 and is based in Chicago, Illinois.


DEAL STATS #
Overall 130 of 152
Sector: Life Science M&A 20 of 23
Type: Venture M&A Deals 89 of 102
State: Washington M&A 3 of 3
Country: United States M&A 118 of 140
Year: 2019 M&A 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-19 Spiceworks

Austin, Texas, United States

Spiceworks is a provider of network management and social software for SMB IT professionals. Spiceworks is based in Austin, Texas.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-18 Epirium Bio

San Diego, California, United States

Epirium Bio is a clinical-stage biopharmaceutical company that has developed unique insights related to the biology of mitochondrial biogenesis and tissue function, potentially resulting in novel and clinically significant therapeutic approaches to currently intractable neuromuscular diseases. Epirium Bio is based in San Diego, California.

Buy -